Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MBK-01 for Recurrent Diverticulitis (DIREBIOT)
NCT06687382Phase 2Recruiting
- Sponsor
- Mikrobiomik
- Start
- Apr 2025
- Primary completion
- Apr 2027
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 2 trial of MBK-01 in diverticulitis, sponsored by Mikrobiomik. Started Apr 2025; status: recruiting.
02
Drugs
MBK-01
03
Conditions
diverticulitis
Beyond the preview
Go deeper on NCT06687382.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06687382.